Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study

BACKGROUND: Endocan (EN) was suggested a potential inflammatory and cardiovascular disease (CVD) marker which might also be involved in renal failure and/or renal failure-associated vascular events. It is not clear whether osteoprotegerin (OPG) is a pro- or anti-atherogenic factor, however, it is ag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cardiovasc Disord
Autors principals: Sponder, Michael, Campean, Ioana-Alexandra, Emich, Michael, Fritzer-Szekeres, Monika, Litschauer, Brigitte, Bergler-Klein, Jutta, Graf, Senta, Strametz-Juranek, Jeanette
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217648/
https://ncbi.nlm.nih.gov/pubmed/28056805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-016-0452-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars